transient and nitric oxide (NO) levels in the intact coronary arterial endothelium preparation, 8-bromo-cADPR (30 M), ryanodine (50 M) , and nicotinamide (6 mM) substantially attenuated BK (1 M)-induced increase in intracellular [Ca 2ϩ ] by 78%, 80%, and 74%, respectively, whereas these compounds significantly blocked BKinduced NO increase by about 80%, and inositol 1,4,5-trisphosphate receptor blockade with 2-aminethoxydiphenyl borate (50 M) only blunted BK-induced Ca 2ϩ -NO signaling by about 30%. With the use of cADPR-cycling assay, it was found that inhibition of ADP-ribosyl cyclase by nicotinamide substantially blocked BK-induced intracellular cADPR production. Furthermore, HPLC analysis showed that the conversion rate of ␤-nicotinamide guanine dinucleotide into cyclic GDP ribose dramatically increased by stimulation with BK, which was blockable by nicotinamide. However, U-73122, a phospholipase C inhibitor, had no effect on this BK-induced increase in ADP-ribosyl cyclase activity for cADPR production. In conclusion, these results suggest that cADPR importantly contributes to BK-and A-23187-induced NO production and vasodilator response in coronary arteries through its Ca 2ϩ signaling mechanism in CAECs.
nucleotide; vasodilation; endothelium; endothelium-derived relaxing factor CYCLIC ADP RIBOSE (cADPR), endogenously generated from nicotinamide (Ni) adenine dinucleotide, has emerged as a novel intracellular Ca 2ϩ -mobilizing second messenger in a wide variety of mammalian cells. The actions of this signaling nucleotide are completely independent of the inositol 1,4,5-trisphosphate [Ins(1,4,5)P 3 ]-signaling pathway, but it exerts its action by targeting ryanodine (Ry) receptors (RyRs) (8, 15, 16, (31) (32) (33) 44) . Elevation of intracellular cADPR levels followed by Ca 2ϩ mobilizition and activation of Ca 2ϩ -dependent effects within cells has been found to be essential for versatile physiological processes, such as cell cycle regulation, cell proliferation, gene expression, egg fertilization, neurotransmitter release, muscle contraction, and nitric oxide signaling (10, 29, 55) . Recent studies (17, 35, 36, 52, 55, 57) in our laboratory and by others have reported that in vascular smooth muscle (VSM), cADPR production participates in its constrictor response to Ins(1,4,5)P 3 -independent agonists, such as acetylcholine, oxotremorine, 5-hydroxytryptamine, and endothelin, and these actions of cADPR are associated with activation of RyRs and consequent Ca 2ϩ mobilization. However, so far it remains unclear whether cADPR is involved in the regulation of endothelial function, in particular, in participating in endothelial NO-dependent vasodilator response.
It has been reported that Ca 2ϩ activation of endothelial cells is one of the most important mechanisms mediating the production of endothelium-derived relaxing factors (EDRFs), such as NO and prostacyclins (17, 50, 54, 56) , thereby mediating endothelium-dependent vasodilation (EDVD). Despite extensive studies, it has still been controversial which Ca 2ϩ signaling pathway is responsible for the elevation of intracellular Ca 2ϩ in endothelial cells in the process of EDVD. In regard to the regulation of Ca 2ϩ level in the vascular endothelium, it has been demonstrated that on stimulation with inflammatory agonists, such as thrombin, histamine, bradykinin (BK), and oxidants, the intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) could increase 5-10 times compared with the basal level. This agonist-induced increase in [Ca 2ϩ ] i occurs in two distinct phases, a transient rise due to intracellular Ca 2ϩ store depletion, which involves generation of Ins(1,4,5)P 3 and Ins(1,4,5)P 3 -induced Ca 2ϩ release from the endoplasmic reticulum (ER), and a sustained phase due to Ca 2ϩ entry into the cell from extracellular medium (Ca 2ϩ influx). Increased intracellular Ca 2ϩ levels, either Ca 2ϩ influx or release, were found to stimulate the enzymatic binding of Ca 2ϩ /calmodulin (CaM) to endothelial NO synthase (eNOS), resulting in rapid conversion of L-arginine into citrulline, producing NO (14, 42, 49) . However, there is considerable evidence that blockade of Ins(1,4,5)P 3 signaling could only partially attenuate agonistinduced Ca 2ϩ release as well as store-operated calcium influx and partially decreased NO production in endothelial cells (11) . Other studies have reported that Ins(1,4,5)P 3 is not involved in the regulation of BK-induced Ca 2ϩ increase in endothelial cells (21) and that cyclopiazonic acid-enhanced Ca 2ϩ increase and EDRF release in bovine pulmonary arterial endothelial cells is not Ins(1,4,5)P 3 dependent (39) . In addition, the activation of protein tyrosine kinases and phosphatases is also found to participate in the process of endothelial NO generation independently of the phospholipase C signaling pathway (13) . Interestingly, ADP-ribosyl cyclase was recently reported to give rise to BK signal transduction from receptors to its effector enzymes (9, 23, 25) . Based on these results, we hypothesized that cADPR may serve as an intracellular second messenger in mediating BK-induced Ca 2ϩ mobilization in arterial endothelial cells and thereby stimulates the production of NO and participates in the EDVD.
To test this hypothesis, we first examined the effects of cADPR antagonist, ADP-ribosyl cyclase inhibitor, and RyRs blocker on BK-induced vasodilation by using pressurized intact small bovine coronary arterial preparation. By simultaneously measuring [Ca 2ϩ ] i and NO production in the intact endothelium of small bovine coronary arteries using a highspeed wavelength-switching fluorescence imaging system, we then determined the contribution of this cADPR signaling pathway to Ca 2ϩ release and NO production induced by BK receptor activation or Ca 2ϩ ionophore A-23187. Moreover, to directly measure the effects of BK on cADPR production in isolated coronary arterial endothelial cells (CAECs), we quantified the intracellular cADPR levels using cADPR cycling assay and determined BK-induced changes in intracellular cADPR levels. We then went to analyze the effects of BK on the activity of ADP-ribosyl cyclase to produce cADPR in bovine CAECs using HPLC technique. In addition, the role of Ins(1,4,5)P 3 signaling pathway in the endothelial NO production was also observed. Our results provide strong evidence that cADPR-mediated Ca 2ϩ signaling pathway is importantly involved in the production of NO and EDVD in coronary arteries.
MATERIALS AND METHODS

Microdissection and microperfusion of small coronary artery.
Fresh bovine hearts were obtained from a local abattoir. The left ventricular wall was rapidly dissected and immersed in ice-cold physiological saline solution (PSS) containing (in 10 Ϫ3 M) 119 NaCl, 4.7 KCl, 1.6 CaCl2, 1.17 MgSO4, 1.18 NaH2PO4, 24 NaHCO3, 0.026 EDTA, and 5.5 glucose (pH 7.4). This myocardial section was immediately transported to the laboratory. Small intramural coronary arteries from the left anterior descending artery were carefully dissected and placed in cold PSS until cannulation (up to 4 h). Segments of small arteries (100 -200 m, internal diameter) were transferred to a water-jacketed perfusion chamber and cannulated with two glass micropipettes at their in situ length, as we described previously (59) . The outflow cannula was clamped, and the arteries were pressurized to 60 mmHg. The superfusate (PSS) in the bath was bubbled with 95% O 2-5% CO2 and maintained at pH 7.4 and 37°C. This condition for isolated artery preparation was chosen based on a number of previous studies (3, 34, 43, 47, 59) . Because there is no hemoglobin in the superfusate, enough O 2 supply is needed to maintain tissue PO2 for normal endothelial and VSM function. By adjusting bubbling rate, an appropriate balance of O2 supply and consumption could be reached, which maintains an appropriate environment for studies of vasomotor responses in this isolated artery preparation (34, 43, 59) . The internal diameter of arteries was measured with a video system composed of a stereomicroscope (Leica MZ8), a charge-coupled device camera (KP-MI AU, Hitachi), a video monitor (VM-1220U, Hitachi), a video measuring apparatus (VIA-170, Boeckeler Instrument), and a video printer (UP890 MD, Sony). The arterial images were continuously recorded with a videocassette recorder (M-674, Toshiba).
After a 60-min equilibration period, the arteries were precontracted by ϳ50% of their resting diameter with the thromboxane A2 analog U-46619. Once steady-state contraction was obtained, cumulative dose-response curves to the endothelium-dependent vasodilator BK (10 Ϫ10 -10 Ϫ6 M) were determined by measuring changes in the internal diameter. To examine the contribution of the cADPR signaling pathway to BK-induced vasodilator response, the arteries were perfused by lumen and pretreated for 30 min with one of the following compounds: Ni (6 mM, an inhibitor of ADP-ribosyl cyclase), 8-bromo-cADPR (30 M, 8-Br, a cADPR antagonist), Ry (50 M, an antagonist of RyRs), and dose-response curves to the vasodilator were further established. As done in our previous studies, to prevent the interaction of different drugs, various inhibitors were added into lumen perfusate, but BK was added into the bath solution separately. Between pharmacological interventions, the arteries were washed three times with PSS and allowed to equilibrate in drug-free PSS for 20 -30 min. The vasodilator response was expressed as percent relaxation of U-46619-induced precontraction based on changes in the internal diameter of the arteries. The inhibition efficiency was then calculated based on these curves of dilator response to cumulative addition of BK (10 Ϫ10 -10 Ϫ6 M) in the absence and presence of inhibitors, such as Ni, 8-Br, or Ry, at each corresponding dose. PSS in the bath was continuously bubbled with 95% O 2-5% CO2 and maintained at 37 Ϯ 0.1°C throughout the experiment.
Fluorescent imaging measurement of [Ca 2ϩ ]i and NO levels in intact endothelium of coronary arteries. As Li's laboratory (54) described previously, a fluorescence imaging analysis system was set up to simultaneously monitor [Ca 2ϩ ]i and intracellular NO levels. In brief, the longitudinally cut-open arterial segment was put into a recording chamber with the vessel lumen side downward facing the objective of an inverted microscope. Care was taken to keep the endothelium intact. The chamber was filled with Hanks' buffered saline solution containing (in mM) 137 NaCl, 5.4 KCl, 4.2 NaHCO 3, 3 Na 2HPO4, 0.4 KH2PO4, 1.5 CaCl2, 0.5 MgCl2, 0.8 MgSO4, 10 glucose, and 10 HEPES (pH 7.4). After a 30-min equilibration, the artery was loaded with fura-2 AM (10 M) as an indicator for [Ca 2ϩ ]i as well as 4,5-diaminofluorescein (DAF-2) diacetate (DAF-2 DA, 10 M) for NO. After dye loading for 40 min at room temperature was completed, individual endothelial cells on the endothelium of coronary arteries were visualized by an inverted microscope with epifluorescence at attachments. With a digital camera, the fluorescence images were then captured and analyzed as follows. A fura-2 fluorescence ratio of excitation at 340 nm to that at 380 nm (F 340/F380) was determined to calculate [Ca 2ϩ ]i. In contrast, endothelial NO production was first expressed as a relative fluorescence (f), which is the net increment of DAF-2 fluorescence at excitation/emission of 480/535 nm relative to its basal value (f ϭ ⌬F/F 0 ϫ 1,000), where F is DAF-2 fluorescence intensity obtained during experiments and F 0 is its basal fluorescence intensity. Then a differential conversion of time-dependent NO-DAF-2 fluorescence curve (df/dt) was performed to accurately calculate NO production rate and plotted against the reaction time and presented this curve with [Ca 2ϩ ]i changes in parallel. The area under the curve (AUC) of df/dt was calculated to represent the cumulative amount of NO in the cells.
BK (10 Ϫ6 M) was added to the bath solution to stimulate NO production. To examine the contribution of the cADPR pathway to BK-induced change of [Ca 2ϩ ]i and endothelial [NO] , the arteries were respectively preincubated for 30 min with Ni (6 mM), 8-Br (30 M), or Ry (50 M), and the response to BK was then determined. Fluorescent image was measured every 10 min in a single area of the endothelial layer. Results were expressed as the integrated fluorescence intensity within the area observed. In addition, the contribution of this cADPR pathway to the effect of A-23187 (2 M), a receptorindependent activator of NO production, was monitored. To clarify the possible involvement of Ins(1,4,5)P3 pathway in BK-induced increase in [Ca 2ϩ ]i and endothelial [NO] , the arteries were also preincubated for 30 min with 2-aminethoxydophenyl borate (2-APB, 50 M) or 2-APB together with 8-Br in parallel.
Culture of CAECs. The bovine coronary arterial endothelial cells (BCAECs) were cultured as described previously (58) . Briefly, the arteries were rinsed with RPMI 1640 containing 5% FCS, 2% penicillin-streptomycin solution, 0.3% gentamicin, and 0.3% nystatin, as well as cleaned-off connective tissues. The lumen of the arteries was filled with 0.25% collagenase type II (Sigma) in RPMI 1640 and incubated at 37°C for 30 min. The arteries were then flushed with RPMI 1640, and the detached endothelial cells were collected, cultured in RPMI 1640 (containing 25% FCS, 1% glutamine, and 1% penicillin-streptomycin solution), and maintained in an incubator with 5% CO2-95% room air at 37°C. The endothelial cells were identified by their morphological appearance (i.e., cobblestone array) and by positive staining for von Willebrand factor antigen. All studies were performed by using the cells of 3 to 4 passages. Cycling assay for intracellular cADPR level. The cADPR basal level in cultured BCAECs was determined as described previously (20) . About 6 ϫ 10 6 cultured CAECs per sample were used. After respectively exposed to Ni (6 mM), U-73122 (100 nM), or vehicle solution, followed by the presence of a differential concentration of BK (0.5, 1, and 2 M) at 37°C for 5 min, CAECs were scraped by a plastic scraper and spined down by centrifugation. The centrifugal pellets were extracted with 0.5 ml of 0.6 M perchloric acid at 4°C. Perchloric acid was removed by mixing the aqueous sample with a solution containing 3 vol of 1,1,2-trichlorotrifluoroethane to 1 vol of tri-n-octylamine. After centrifugation for 10 min at 1,500 g was completed, the aqueous layer containing the cADPR was removed and then incubated overnight at 37°C with a enzyme mixture containing 0.44 unit/ml nucleotide pyrophosphatase, 12.5 units/ml alkaline phosphatase, 0.0625 unit/ml NADase, 2.5 mM MgCl 2, and 20 mM sodium phosphate (pH 8.0). All nucleotides except cADPR in the samples were hydrolyzed.
Reactions were conducted in 96-well plates. Added to 0.1 ml of cADPR or other nucleotide samples were 50 l of reagent containing 0.3 g/ml ADP-ribosyl cyclase, 30 mM nicotinamide, and 100 mM sodium phosphate (pH 8). This initiated the conversion of cADPR in the samples to NAD ϩ . The conversion was allowed to proceed for 15 min at room temperature. The cycling reagent (0.1 ml) was then added, which contained 2% ethanol, 100 g/ml alcohol dehydrogenase, 20 M resazurin, 10 g/ml diaphorase, 10 M flavin mononucleotide, 10 mM nicotinamide, 0.1 mg/ml BSA, and 100 mM sodium phosphate (pH 8). The cycling reaction was allowed to proceed for 2-4 h, and the increase in the resorufin fluorescence (with excitation at 544 nm and emission at 590 nm) was measured periodically using a fluorescence plate reader. With known concentrations of standards cure, quantitative measurements were performed. The results shown are means Ϯ SE from at least three independent measurements.
HPLC analysis of ADP-ribosyl cyclase activity. Cultured CAECs at confluence were rinsed three times with 10 ml of chilled PBS and collected by using a cell scraper at 4°C. The cells were divided into four different Eppendorf tubes (1 ml each) and preincubated at 37°C for 10 min. To examine the effects of BK, Ni, and U-73122 on ADP-ribosyl cyclase activity, CAECs were treated with BK (1 M) in the presence of Ni (6 mM), U-73122 (100 nM), or PBS (control), respectively. After incubation at 37°C for 15 min was completed, the cells were washed with Hanks' solution. The pellets of cells were suspended in HEPES buffer containing (in mM) 10 HEPES, 148 NaCl, 5 KCl, 1.8 CaCl 2, 0.3 MgCl2, and 5.5 glucose (pH 7.0). They were then sonicated 6 times (each time for 20 s) with a sonifier cell disrupter (model 185, Branson) at 4°C. After centrifugation at 3,500 g for 10 min was completed, the supernatant was collected. To determine ADP-ribosyl cyclase activity, the supernatant of 100 g of protein was incubated with 100 M of ␤-nicotinamide guanine dinucleotide (␤-NGD ϩ ) at 37°C for 60 min. The reaction mixtures were centrifuged at 4°C through an Amicon microultrafilter at 13,800 g to remove proteins and then analyzed by HPLC with a fluorescence detector (Hewlett-Packard 1090 HPLC system and 1046Å spectrofluorometer). The excitation wavelength of 300 nm and the emission wavelength of 410 nm were used to detect the fluorescent products. All HPLC data were collected and analyzed by a Hewlett-Packard Chemstation.
Nucleotides were resolved on a 3-m Supelcosil LC-18 column (4.6 ϫ 150 mm) with a 5-m Supelcosil LC-18 guard column (4.6 ϫ 20 mm; Supelco, Bellefonte, PA). The injection volume was 20 l. The mobile phase consisted of 150 mM ammonium acetate (pH 5.5) containing 5% methanol (solvent A) and 50% methanol (solvent B). The solvent system was a linear gradient of 5% solvent B in A to 30% solvent B in A over 1 min, held for 25 min, and then increased to 50% solvent B over 1 min. The flow rate was 0.8 ml/min. Peak identities were confirmed by commigration with known standards. Quantitative measurements were performed by comparison of known concentrations of standards (17, 18, 34) .
Statistics. Data are expressed as means Ϯ SE. The significance of the differences in mean values between and within multiple groups was examined by using ANOVA for repeated measures, followed by Duncan's multiple range test. Student's t-test was used to evaluate the statistical significance of differences between two paired observations. P Ͻ 0.05 was considered statistically significant.
RESULTS
Effects of 8-Br, Ry, and Ni on BK-induced vasodilation in intact bovine small coronary arteries.
To explore whether cADPR antagonist 8-Br, Ry receptor blocker Ry, and ADPribosyl cyclase inhibitor Ni have effects on the EDVD response to BK, the concentration-response curves of BK were first determined in each group as control. The vasodilator response to BK was then redetermined in the presence of various inhibitors, respectively. As shown in Fig. 1A ] i and NO level in this intact endothelium. Pretreatment of the endothelium with 8-Br, although it had no effect on the basal F 340 /F 380 ratio of fura-2 and DAF-2 fluorescence in the endothelium, significantly attenuated BK-induced changes in fura-2/Ca 2ϩ signal and substantially blocked the DAF-2/NO signal. To validate that these signals are from endothelial cells, some arteries were deendothelized and the fluorescent images were acquired again when BK was added. It was demonstrated that neither fura-2 nor DAF-2 signal could be observed in the deendothelized arteries. We also performed experiments to confirm the specificity of these two signals by use of L-NAME to block NOS activity. In these experiments, it was found that N G -nitro-L-arginine methyl ester (L-NAME) increase in DAF-2/NO fluorescence intensity was dramatically blocked. Figure 2C also (Fig. 3, A and  B) . Moreover, both blockade of RyRs by 50 M Ry and inhibitor of ADP-ribosyl cyclase by Ni significantly reduced the peak Ca 2ϩ response to BK and markedly downregulated BK-induced NO increase in endothelial cells (Fig. 4, A and B) .
To assess the contribution of cADPR and Ins(1,4,5)P 3 signaling pathway to the BK-induced endothelial [Ca 2ϩ ] i and NO level in the intact coronary arterial endothelium, blockade of Ins(1,4,5)P 3 signaling by 2-APB (50 M) and/or inhibition of cADPR signaling by 8-Br (30 M) were performed in the endothelium preparation before the addition of BK. As shown in Fig. 5A , inhibition of Ins(1,4,5)P 3 signaling alone causes a mild decrease in [Ca 2ϩ ] i as well as endothelial NO. However, pretreatment with 2-APB and 8-Br together substantially blocked the peak Ca 2ϩ response to BK and completely abolished BK-induced NO increase in endothelial cells (Fig. 5B) . levels under control condition. However, 2-APB alone partially blocked BK-stimulated NO increase (⌬AUC by 96 Ϯ 5, n ϭ 8 arterial preparations), whereas this endothelial NO production was completely blocked in the presence of 2-APB and 8-Br together.
Effects of Ni on BK-induced cADPR increase in CAECs.
Using cultured CAECs, we determined cADPR levels in the absence or presence of BK. As summarized in Fig. 7A , cADPR was detectable in CAECs with a concentration range at 1-5.5 pmol/mg protein. In the control CAECs, the basal level of cADPR was 2.29 Ϯ 0.16 pmol/mg protein (n ϭ 8 experiments). When the CAECs were stimulated with BK for 5 min, the intracellular cADPR level substantially increased. Interestingly, the relative higher response to BK, a 5.82 Ϯ 0.79 pmol/mg protein increase in cADPR concentration, was not found at 2 M but at a 1 M BK dose (n ϭ 8 experiments, P Ͻ 0.05). Inhibition of ADP-ribosyl cyclase with Ni (6 mM) significantly reduced both cADPR basal levels and BK-induced cADPR generation by about 40% reduction (n ϭ 8 experiments). However, the addition of U-73122 (100 nM) was not found to inhibit BK (1 M)-induced intracellular cADPR generation (Fig. 7B, n ϭ 8 experiments) .
ADP-ribosyl cyclase activity in CAECs. By fluorescence HPLC analysis, cyclic GDP ribose (cGDPR) production converted from ␤-NGD ϩ by cultured CAECs was measured, which indicated ADP-ribosyl cyclase activity in CAECs. This conversion of ␤-NGD ϩ into cGDPR was used because cGDPR cannot be metabolized by ADP-ribosyl cyclase, leading to more accurate quantities of ADP-ribosyl cyclase. This product coeluted with the cGDPR standard at a retention time of 2.2 min. Under control conditions, the conversion rate of ␤-NGD ϩ into cGDPR was 33.15 Ϯ 2.72 pmol⅐min Ϫ1 ⅐mg protein
Ϫ1
(n ϭ 6 experiments). When CAECs were incubated with BK, a concentration-dependent increase in cGDPR production was observed. BK significantly stimulated the production of cGDPR, even at 1 min incubation time point (data not shown).
The maximal conversion rate of ␤-NGD ϩ to cGDPR was 49.18 Ϯ 0.93 pmol ⅐min Ϫ1 ⅐mg protein Ϫ1 (n ϭ 6 experiments), which was observed at 1 M BK with 5 min of incubation with CAECs. In the presence of the ADP-ribosyl cyclase inhibitor Ni (6 mM), BK-induced increase in the conversion of ␤-NGD ϩ to cGDPR was substantially inhibited (n ϭ 6 experiments), and even at the highest concentration studied, BK (10 M) could not increase the activity of ADP-ribosyl cyclase. In contrast, U-73122 had no effect on BK (1 M)-induced activation of ADP-ribosyl cyclase (n ϭ 8 experiments) (shown as Fig. 8 ). 
DISCUSSION
In the present study, we demonstrated that inhibition of cADPR production significantly attenuated BK-induced concentration-dependent coronary arterial vasodilation. In the intact coronary arterial endothelium, BK evoked Ca 2ϩ release from RyRs-sensitive stores in CAECs, which was accompanied by an increase in NO production. Moreover, we confirmed that this BK-induced intracellular Ca 2ϩ increase and NO response is not mainly associated with Ins(1,4,5)P 3 signaling but with cADPR levels in these cells. cADPR cyclase activation by BK may contribute to enhanced production of cADPR. We also demonstrated that blockade of cADPR production significantly attenuated endothelial intracellular Ca 2ϩ increase and NO generation in response to another stimulator, Ca 2ϩ ionophore A-23187, of NO production in the endothelium. These results suggest that cADPR-mediated Ca 2ϩ signaling plays an important role in the regulation of endothelial NO production and thereby plays a critical role in EDVD. It is well known that the EDVD is of importance in the regulation of coronary circulation, which is involved in the actions of increased vasoactive agents such as arachidonic acid (41) , ATP (4, 28) , acetylcholine (1), A-23187 (46) , and BK (7, 40) . Both BK-and A-23187-induced vasodilation is linked to the release of endothelium-derived NO (7, 40) , prostaglandin I 2 (38) , and endothelium-dependent hyperpolarizing factor, such as epoxyeicosatrienoic acids (6), and BK is considered as a more classic Ca 2ϩ -dependent activator of eNOS (5, 53) . As reported in a previous study from Li's laboratory (54) , BK can produce a rapid and simultaneous increase in intracellular Ca 2ϩ and endothelial NO. This BK-induced NOS activation is largely dependent on intracellular Ca 2ϩ mobilization and subsequent binding of Ca 2ϩ /CaM to eNOS and displacement of eNOS from caveolin-1 (12, 19) . Moreover, many studies have been reported on the role of Ca 2ϩ influx (2, 30) , Ca 2ϩ -mobilizing second messenger, and relative receptors in the endothelial intracellular Ca 2ϩ release (11, 13, 27, 39, 45) . Recently, a cellular spatiotemporal organization pattern for Ca 2ϩ mobilization under the plasma membrane in endothelial cells has been indicated to be critical for the regulation of NO generation (26) . However, the mechanism by which BK leads to such Ca 2ϩ increase still remains very controversial and has yet to be clarified.
The present study first explored the role of the cADPR signaling pathway in mediating BK-induced vasodilation in perfused and pressurized small coronary arteries. We found that inhibition of cADPR production or antagonism of its action significantly attenuated BK-induced vasodilation in these coronary arteries. Moreover, consistent with the previous findings that cADPR acts via RyRs-mediated Ca 2ϩ mobilization from the sarcoplasmic reticulum, the present study confirmed that exogenous application of a large dose of Ry markedly impaired the vasodilator response of coronary arter- ies to BK. To our knowledge, these results provide the first direct evidence that a cADPR signaling pathway is involved in the vasodilator response to BK in coronary circulation.
To determine whether BK-induced response is directly linked to cADPR-mediated Ca 2ϩ release from the ER in CAECs, a newly developed fluorescence imaging system was used to simultaneously measure Ca 2ϩ transient and NO production in the intact coronary endothelium under control conditions or during blockade of cADPR-RyRs signaling. In these experiments, BK was found to produce a rapid and transient increase in Ca 2ϩ through intracellular mobilization and Ca 2ϩ influx, which was accompanied by an increase in intracellular NO. However, when the arteries were pretreated with cADPRRyRs signaling inhibitors or blockers, Ni, 8-Br, or Ry separately, BK-induced Ca 2ϩ release was significantly attenuated and NO production was obviously blocked. This supports the view that BK stimulates Ca 2ϩ release in CAECs through cADPR-RyRs signaling pathway.
It should be noted that the present findings do not rule out the role of Ins(1,4,5)P 3 -mediated Ca 2ϩ signaling in BK-induced NO production. It is well known that Ins(1,4,5)P 3 -mediated Ca 2ϩ signaling is generally present in various mammalian cells and via G protein-coupled B 2 receptor BK may activate Ins(1,4,5)P 3 signaling pathway (11, 27) . In the present study, however, blockade of Ins(1,4,5)P 3 pathway by 2-APB was only found to partially inhibit the intracellular Ca 2ϩ mobilization and NO production induced by BK. If 8-Br together with 2-APB was used to treat the intact endothelium of coronary arteries, the BK-induced Ca 2ϩ release response was blocked more substantially compared with that by using 8-Br alone. These results are consistent with other evidence that the maximal inhibition effect of carboxyamidotriazole on vascular endothelial growth factor A-induced NO production in human umbilical vein endothelial cells was only ϳ50% depending on Ins(1,4,5)P 3 pathway (11). In addition, ϳ50% inhibition of BK-induced vasodilation with Ͼ80% inhibition of Ca 2ϩ and NO increase by inhibition of cADPR-RyRs signaling pathway also indicates that BK-induced vasodilaition is not only associated with Ca 2ϩ -NO-mediated mechanism. It is possible that cADPR primarily influences BK-induced coronary vasodilation via its Ca 2ϩ release and consequent NO production. There is a concern whether this cADPR-Ca 2ϩ -NO regulation is only specific to BK-induced response. However, our results indicate that cADPR signaling seems to be involved in a general process of endothelial Ca 2ϩ and NO response because 8-Br, an antagonist of cADPR, also markedly blunted A-23187-induced Ca 2ϩ increase and NO production in endothelial cells.
Through biochemical analysis, we further provided evidence that cADPR production was activated by BK. Using a fluorescence cycling assay, we found that stimulation CAECs with BK caused a significant increase in intracellular cADPR levels. Consistent with previous results in sea urchin eggs and other tissues or cells, the concentration of cADPR in CAECs was found at a range of picomole per milligram of tissue protein, which by calculation is relative to a tissue level of nanomoles (37, 48, 51) . When these CAECs were challenged by BK, intracellular cADPR levels were significantly increased. Inhibition of ADP-ribosyl cyclase with Ni significantly reduced this BK-induced cADPR generation. However, inhibition of phospholipase C by U-73122 did not influence either basal or BK-induced cADPR levels. These biochemical results further strengthened the conclusion from our functional studies in the arteries or CAECs that BK stimulates cADPR production and thereby activates NO generation, which produces EDVD.
To define the enzymatic pathway for BK-induced elevation of cADPR in CAECs, we performed HPLC analysis to determine the activation of ADP-ribosyl cyclase by BK. It was demonstrated that incubation of CAECs with BK produced a concentration-dependent enhancement of ADP-ribosyl cyclase activity, which could be significantly blocked by its inhibitor Ni and not by phospholipase C inhibitor U-73122. This activation of ADP-ribosyl cyclase occurred rapidly even in the first minute of the incubation of CAECs with BK. In previous studies, the regulation of ADP-ribosyl cyclase has been found to be involved in several membrane or cytosolic receptors, such as muscarinic acetylcholine receptors in NG108 -15 neuronal cells (24) , angiotensin II or ␤-adrenergic receptors in ventricular myocytes (22) , and M 1 muscaric receptors in VSM cells (17) . It has been proposed that these receptors could be directly coupled with ADP-ribosyl cyclase, and, therefore, their activation could result in increased production of cADPR (22, 24) . With respect to BK, there is evidence that B 2 receptors are directly coupled to the membrane-bound form of ADP-ribosyl cyclase in human airway smooth muscle cells (9) or NG108 -15 neuronal cells (23) , suggesting that BK could stimulate cADPR production via this coupling mechanism. The present study did not attempt to explore this detail coupling mechanism; however, our results suggest that BK could potentially stimulate ADP-ribosyl cyclase through this coupling because BK-induced Ca 2ϩ response and cADPR production are rather rapid.
In summary, the present study demonstrated the following. First, inhibition of cADPR production and antagonism of its action significantly impaired BK-induced EDVD in the intact bovine small coronary arteries. Second, in the intact endothelium of coronary arteries, inhibition of cADPR-RyRs Ca 2ϩ signaling pathway not only substantially decreased BK-induced Ca 2ϩ release but also substantially blocked BK-induced NO generation. Third, BK was found to increase intracellular cADPR levels, and inhibition of cADPR cyclase with Ni significantly reduced this BK-induced increase in cADPR levels. Fourth, BK-induced increase in intracellular cADPR levels was associated with activation of ADP-ribosyl cyclase. Fifth, in addition, the contribution of cADPR to Ca 2ϩ /NO release was found linked to the response to other agonists, such as A-23187. Therefore, we conclude that cADPR-mediated Ca 2ϩ represents an important Ca 2ϩ signaling mechanism, which importantly contributes to BK-induced NO production in coronary arteries via its Ca 2ϩ mobilization action. Therefore, this signaling nucleotide is of importance in the regulation of EDVD response in coronary circulation.
GRANTS
This study was supported by National Institutes of Health Grants DK-54927, HL-57244, HL-75316, and HL-70726.
